GOLD guidelines adherence impact on the NHS budget
DOI:
https://doi.org/10.7175/fe.v15i1.887Keywords:
COPD, GOLD guidelines, AdherenceAbstract
OBJECTIVE: Aim of this study was the evaluation of the adherence level to GOLD guidelines for the COPD patients’ treatment in the Italian GPs setting, observing the time trend on ICS therapies’ pharmacoutilization, specifically in mild and moderate COPD patients, which is considered inappropriate by GOLD guidelines. Moreover, a pharmacoeconomic analysis has been implemented in order to evaluate the economical burden of the improper management of COPD.
METHODS: The retrospective GPs database study has analyzed patients with at least one diagnosis of COPD during the periods January 2005 – December 2008 (Cohort 1) and January 2009 – December 2011 (Cohort 2), who had a reported value of VEMS, at least one prescription of a drug from ATC R03 class within two months from the date of spirometric exam and aged 40 or more. Disease severity has been defined according to 2008 GOLD guidelines. Comparison between the cohorts has been implemented to verify possible variations in guideline adherence. Furthermore, an economical analysis has been developed in order to highlight saves obtained by following GOLD guidelines and the total inappropriate therapies’ costs.
RESULTS: The first cohort involved 2,103 COPD patients, while the second cohort included 1,647 subjects. Reduction of ICS therapies has been shown between the two cohorts, with a decrease of 8.4% for mild patient and 1.6% for moderate patients; considering all the disease severities, the reduction was about 4%. Pharmacoeconomic analysis on mild and moderate patients has pointed out that about 50% of the total ICS treatments (814,692 € on 1,658,164 €) is related to the ICS element, and so considered inappropriate costs.
CONCLUSION: Economic differences between the two periods have highlighted a minor mean costs for Cohort 2, underlining an improvement in the adherence to the GOLD guidelines in the last period.
References
Mannino DM, Brown C, Giovino GA. Obstructive lung disease deaths in the United States from 1979 through 1993. An analysis using multiple-cause mortality data. Am J Respir Crit Care Med 1997; 156: 814-8; http://dx.doi.org/10.1164/ajrccm.156.3.9702026
Mathers CD, Loncar D. Projections of Global Mortality and Burden of Disease from 2002 to 2030. PLoS Med 2006; 3: e442; http://dx.doi.org/10.1371/journal.pmed.0030442
Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. Update 2013
Pauwels RA, Buist AS, Calverley PM, et al.; GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001; 163: 1256-76; http://dx.doi.org/10.1164/ajrccm.163.5.2101039
World Health Report. Geneva: World Health Organization
Rycroft CE, Heyes A, Lanza L, et al. Epidemiology of COPD: a literature review. Int J Chron Obstruct Pulmon Dis 2012; 7: 457-94; http://dx.doi.org/10.2147/COPD.S32330
Gini R, Francesconi P, Mazzaglia G, et al. Chronic disease prevalence from Italian administrative databases in the VALORE project: a validation through comparison of population estimates with general practice databases and national survey. BMC Public Health 2013; 13: 15; http://dx.doi.org/10.1186/1471-2458-13-15
Indagini Multiscopo ISTAT sulle famiglie. ISTAT, 2010
Mathers C, Boerma T, Ma Fat D. The Global Burden of Disease: 2004 Update. World Health Organization 2008. Disponibile su www.who.int/healthinfo/global_burden_disease/GBD_report_2004update_full.pdf (ultimo accesso luglio 2013)
European Respiratory Society. European Lung White Book: Huddersfield, European Respiratory Society Journals, Ltd; 2003
Reid DJ, Pham NT. Emerging Therapeutic Options for the Management of COPD. Clin Med Insights Circ Respir Pulm Med 2013; 7: 7-15; http://dx.doi.org/10.4137/CCRPM.S8140
Katz P, Pegoraro V. L’utilizzo dei corticosteroidi nei pazienti con la bronco pneumopatia cronica ostruttiva: aspetti epidemiologici ed economici. Farmeconomia e percorsi terapeutici 2009; 10: 139-148
Cazzola M, Bettoncelli G, Sessa E, et al. Primary care of the patient with chronic obstructive pulmonary disease in Italy. Respir Med 2009; 103: 582-8; http://dx.doi.org/10.1016/j.rmed.2008.10.017
Asche CV, Leader S, Plauschinat C, et al. Adherence to current guidelines for chronic obstructive pulmonary disease (COPD) among patients treated with combination of long-acting bronchodilators or inhaled corticosteroids. Int J Chron Obstruct Pulmon Dis 2012; 7: 201-9; http://dx.doi.org/10.2147/COPD.S25805
Sharif R, Cuevas CR, Wang Y, et al., Guideline adherence in management of stable chronic obstructive pulmonary disease. Respir Med 2013; 107: 1046-52; http://dx.doi.org/10.1016/j.rmed.2013.04.001
Jebrak G. COPD routine management in France: Are guidelines used in clinical practice? Rev Mal Respir 2010; 27: 11-8; http://dx.doi.org/10.1016/j.rmr.2009.08.002
Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. Updated 2013
Database IMS Health, Sell Out Italia consuntivo anno 2012, consultato in maggio 2013
American Thoracic Society Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 152: S77-121
Published
Issue
Section
License
>> DISTRIBUTION / LICENSE <<
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. The Publication Agreement can be downloaded here, and should be signed by the Authors and sent to the Publisher when the article has been accepted for publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (see The Effect of Open Access).
- Authors are permitted to post their work online after publication (the article must link to publisher version, in html format)
